Veru Return on Tangible Equity 2010-2025 | VERU
Current and historical return on tangible equity values for Veru (VERU) over the last 10 years. Return on tangible equity can be defined as the amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity.
| Veru Return On Tangible Equity Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Tangible Equity | Return on Tangible Equity |
| 2025-03-31 | $-0.04B | $0.01B | -164.44% |
| 2024-12-31 | $-0.04B | $0.02B | -136.84% |
| 2024-09-30 | $-0.04B | $0.03B | -109.35% |
| 2024-06-30 | $-0.04B | $0.03B | -116.54% |
| 2024-03-31 | $-0.04B | $0.04B | -140.54% |
| 2023-12-31 | $-0.06B | $0.05B | -303.61% |
| 2023-09-30 | $-0.09B | $0.01B | -494.74% |
| 2023-06-30 | $-0.13B | $0.02B | -376.30% |
| 2023-03-31 | $-0.14B | $0.01B | -240.71% |
| 2022-12-31 | $-0.12B | $0.04B | -136.07% |
| 2022-09-30 | $-0.08B | $0.07B | -75.45% |
| 2022-06-30 | $-0.05B | $0.11B | -36.15% |
| 2022-03-31 | $-0.03B | $0.13B | -19.74% |
| 2021-12-31 | $-0.02B | $0.14B | -11.29% |
| 2021-09-30 | $0.01B | $0.14B | 5.98% |
| 2021-06-30 | $0.00B | $0.14B | -1.16% |
| 2021-03-31 | $0.00B | $0.15B | -1.87% |
| 2020-12-31 | $0.00B | $0.04B | 5.48% |
| 2020-09-30 | $-0.02B | $0.02B | -200.00% |
| 2020-06-30 | $-0.01B | $0.01B | -153.85% |
| 2020-03-31 | $-0.01B | $0.00B | -200.00% |
| 2019-12-31 | $-0.01B | $0.00B | -236.36% |
| 2019-09-30 | $-0.01B | $0.01B | -165.52% |
| 2019-06-30 | $-0.02B | $0.01B | -261.54% |
| 2019-03-31 | $-0.02B | $0.01B | -338.46% |
| 2018-12-31 | $-0.02B | $0.01B | -258.82% |
| 2018-09-30 | $-0.02B | $0.00B | -234.15% |
| 2018-06-30 | $-0.02B | $0.01B | -140.00% |
| 2018-03-31 | $-0.01B | $0.01B | -74.67% |
| 2017-12-31 | $-0.01B | $0.02B | -56.47% |
| 2017-09-30 | $-0.01B | $0.02B | -38.71% |
| 2017-06-30 | $-0.01B | $0.02B | -22.64% |
| 2017-03-31 | $0.00B | $0.02B | -13.45% |
| 2016-12-31 | $0.00B | $0.03B | -6.15% |
| 2016-09-30 | $0.00B | $0.03B | 0.00% |
| 2016-06-30 | $0.00B | $0.04B | 8.63% |
| 2016-03-31 | $0.00B | $0.04B | 8.89% |
| 2015-12-31 | $0.01B | $0.04B | 15.27% |
| 2015-09-30 | $0.01B | $0.03B | 16.00% |
| 2015-06-30 | $0.00B | $0.03B | 10.00% |
| 2015-03-31 | $0.00B | $0.03B | 10.26% |
| 2014-12-31 | $0.00B | $0.03B | 3.51% |
| 2014-09-30 | $0.00B | $0.03B | 3.51% |
| 2014-06-30 | $0.01B | $0.03B | 30.77% |
| 2014-03-31 | $0.01B | $0.03B | 31.30% |
| 2013-12-31 | $0.01B | $0.03B | 42.48% |
| 2013-09-30 | $0.02B | $0.03B | 55.56% |
| 2013-06-30 | $0.02B | $0.03B | 63.37% |
| 2013-03-31 | $0.02B | $0.03B | 76.60% |
| 2012-12-31 | $0.02B | $0.02B | 80.00% |
| 2012-09-30 | $0.02B | $0.02B | 82.05% |
| 2012-06-30 | $0.01B | $0.02B | 73.24% |
| 2012-03-31 | $0.01B | $0.02B | 62.50% |
| 2011-12-31 | $0.01B | $0.02B | 52.46% |
| 2011-09-30 | $0.01B | $0.02B | 33.90% |
| 2011-06-30 | $0.01B | $0.01B | 41.38% |
| 2011-03-31 | $0.01B | $0.01B | 42.11% |
| 2010-12-31 | $0.01B | $0.02B | 58.18% |
| 2010-09-30 | $0.01B | $0.02B | 53.85% |
| 2010-06-30 | $0.00B | $0.01B | 24.49% |
| 2010-03-31 | $0.00B | $0.01B | 33.33% |
| 2009-12-31 | $0.00B | $0.01B | 34.78% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.054B | $0.017B |
| Veru Inc. engages in the development, manufacture and marketing of consumer health care products. It focuses on producing FC2 female condom which provides dual protection against unintended pregnancy and sexually transmitted infections. Veru Inc., formerly known as The Female Health Company, is headquartered in Miami, FL. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $227.878B | 26.72 |
| Boston Scientific (BSX) | United States | $152.546B | 36.38 |
| Stryker (SYK) | United States | $143.342B | 29.18 |
| EssilorLuxottica (ESLOY) | France | $134.414B | 0.00 |
| Medtronic (MDT) | Ireland | $114.542B | 16.25 |
| Lonza Group Ag (LZAGY) | Switzerland | $47.355B | 0.00 |
| Haleon (HLN) | United Kingdom | $41.554B | 23.72 |
| ResMed (RMD) | United States | $41.123B | 29.37 |
| Agilent Technologies (A) | United States | $32.165B | 20.97 |
| GE HealthCare Technologies (GEHC) | United States | $31.941B | 15.01 |
| Terumo (TRUMY) | Japan | $25.643B | 33.31 |
| Koninklijke Philips (PHG) | Netherlands | $25.229B | 16.69 |
| Insulet (PODD) | United States | $19.515B | 76.60 |
| Zimmer Biomet Holdings (ZBH) | United States | $18.034B | 11.58 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $15.548B | 0.00 |
| Baxter (BAX) | United States | $11.546B | 8.93 |
| Sunny Optical Technology (SNPTF) | China | $10.417B | 0.00 |
| Demant (WILYY) | Denmark | $8.633B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $7.193B | 26.27 |
| Prestige Consumer Healthcare (PBH) | United States | $3.714B | 16.59 |
| Haemonetics (HAE) | United States | $3.640B | 16.58 |
| Lantheus Holdings (LNTH) | United States | $3.589B | 9.53 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| Envista Holdings (NVST) | United States | $3.275B | 22.92 |
| Perrigo (PRGO) | Ireland | $3.246B | 8.11 |
| ICU Medical (ICUI) | United States | $3.123B | 23.03 |
| LeMaitre Vascular (LMAT) | United States | $2.106B | 45.26 |
| AtriCure (ATRC) | United States | $1.815B | 0.00 |
| QuidelOrtho (QDEL) | United States | $1.585B | 10.02 |
| Green Thumb Industries (GTBIF) | United States | $1.454B | 62.46 |
| AdaptHealth (AHCO) | United States | $1.329B | 18.94 |
| Acuren (TIC) | United States | $1.217B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $1.126B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $1.074B | 13.73 |
| Neogen (NEOG) | United States | $1.036B | 16.45 |
| BioLife Solutions (BLFS) | United States | $1.009B | 0.00 |
| InMode (INMD) | Israel | $0.884B | 8.18 |
| Kestra Medical Technologies (KMTS) | United States | $0.743B | 0.00 |
| Valneva SE (VALN) | France | $0.697B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.621B | 0.00 |
| ZimVie (ZIMV) | United States | $0.531B | 20.46 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.518B | 0.00 |
| Surmodics (SRDX) | United States | $0.501B | 0.00 |
| Owens & Minor (OMI) | United States | $0.497B | 4.12 |
| CeriBell (CBLL) | United States | $0.462B | 0.00 |
| SNDL (SNDL) | Canada | $0.444B | 0.00 |
| Evolus (EOLS) | United States | $0.412B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.354B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.339B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.304B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.302B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.290B | 10.67 |
| Quanterix (QTRX) | United States | $0.280B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.278B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.255B | 18.97 |
| Cerus (CERS) | United States | $0.247B | 0.00 |
| Omeros (OMER) | United States | $0.238B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.238B | 0.00 |
| Brainsway (BWAY) | Israel | $0.224B | 59.20 |
| Sanara MedTech (SMTI) | United States | $0.218B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.215B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.214B | 0.00 |
| Biote (BTMD) | United States | $0.211B | 6.33 |
| Exagen (XGN) | United States | $0.196B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.194B | 0.00 |
| Organigram Global (OGI) | Canada | $0.185B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.183B | 15.04 |
| High Tide (HITI) | Canada | $0.177B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.150B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.149B | 0.00 |
| Safety Shot (SHOT) | United States | $0.145B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.140B | 17.27 |
| Jushi Holdings (JUSHF) | United States | $0.125B | 0.00 |
| MacroGenics (MGNX) | United States | $0.102B | 0.00 |
| Jin Medical (ZJYL) | China | $0.100B | 0.00 |
| Fonar (FONR) | United States | $0.099B | 12.75 |
| Quipt Home Medical (QIPT) | United States | $0.098B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.085B | 0.00 |
| Apyx Medical (APYX) | United States | $0.077B | 0.00 |
| Agape ATP (ATPC) | $0.069B | 0.00 | |
| Cytosorbents (CTSO) | United States | $0.056B | 0.00 |
| ImmuCell (ICCC) | United States | $0.056B | 0.00 |
| Zynex (ZYXI) | United States | $0.047B | 0.00 |
| Modular Medical (MODD) | United States | $0.040B | 0.00 |
| United-Guardian (UG) | United States | $0.036B | 12.60 |
| Rockwell Medical (RMTI) | United States | $0.033B | 0.00 |
| Nephros (NEPH) | United States | $0.032B | 42.86 |
| Allurion Technologies (ALUR) | United States | $0.021B | 0.00 |
| INLIF (INLF) | $0.018B | 0.00 | |
| Trinity Biotech (TRIB) | Ireland | $0.015B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.013B | 0.00 |
| Senestech (SNES) | United States | $0.012B | 0.00 |
| Flora Growth (FLGC) | United States | $0.011B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.010B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.009B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.009B | 0.00 |
| Sharps Technology (STSS) | United States | $0.005B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.003B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| InterCure (INCR) | Israel | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |